Second Generation Analogs of the Cancer Drug Clinical Candidate Tipifarnib for Anti-Chagas Disease Drug Discovery

We previously reported that the cancer drug clinical candidate tipifarnib kills the causative agent of Chagas disease, Trypanosoma cruzi, by blocking ergosterol biosynthesis at the level of inhibition of lanosterol 14α-demethylase. Tipifarnib is an inhibitor of human protein farnesyltransferase. We...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kraus, James M., Tatipaka, Hari Babu, McGuffin, Sarah A., Chennamaneni, Naveen Kumar, Karimi, Mandana, Arif, Jenifer, Verlinde, Christophe L. M. J., Buckner, Frederick S., Gelb, Michael H.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2010
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2877169/
https://ncbi.nlm.nih.gov/pubmed/20429511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/jm9013136
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge